Clinical Trial Update: A Clinical Trial of Human Umbilical Cord Mesenchymal Stem Cell Injection for the Treatment of Severe Acute Respiratory Distress Syndrome [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating injections of human umbilical cord-derived mesenchymal stem cells for severe acute respiratory distress syndrome is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• Human Umbilical Cord Mesenchymal Stem Cell Injection (umbilical cord mesenchymal stem cells)

Snippet

Sponsor: Changchun Tuohua Pharmaceutical Co., Ltd. | Conditions: Acute Respiratory Distress Syndrome | Phase 1, Phase 2 | Status: RECRUITING